June 2, 2026 / Funding
BioPropello Japan market-entry project receives Innowwide / Eureka funding
Funding supports BIOPRO-JP with Agri-Connect in Tokyo.
Read published announcement →Veos Pharmaceuticals, Inc.
News from
Veos Pharma.
Published company announcements, with links to the original releases.
Company news
Published Veos Pharma announcements.
March 11, 2026 / Corporate
Veos Pharma publishes merger-by-absorption announcement
Published notice concerning Veos Pharmaceuticals, S.L. and Veos Ventures, S.L.
Read published announcement →November 14, 2025 / Acquisition
Veos Pharma expands Canadian wellness portfolio
Company announcement on acquiring SSD Trading Canada’s Amazon wellness portfolio.
Read published announcement →October 30, 2025 / Prize
Veos Pharmaceuticals Wins Third Prize at the 9th China (Shenzhen) International Innovation & Entrepreneurship Competition and Advances to Industrial Phase in Shenzhen
Recognition highlights ThymoTropin™ as Veos Pharma's breakthrough natural dual-action myostatin inhibitor and TRPV3 activator.
Read published announcement →August 21, 2025 / Event
Veos Pharmaceuticals Selected to Present at Europe–Japan SALON Part 4, Showcasing OliQuell™ for Green Innovation
Veos to present its breakthrough olive-waste-derived platform at Tokyo event organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation.
Read published announcement →August 21, 2025 / Event
Veos Pharmaceuticals Participating in Smart Energy Week Autumn 2025 Business Mission
OliQuell™, our natural solution for environmental remediation, has been selected for the Smart Energy Week Autumn 2025 Business Mission in Japan.
Read published announcement →